首页 › 慢性阻塞性肺病 › 得克萨斯州 › Houston
Houston TX 慢性阻塞性肺病临床试验
15项针对 慢性阻塞性肺病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
招募中2 期
- Baylor College of Medicine Medical Center, Houston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
招募中3 期
- Trio Clinical Trials- Site Number : 8400106, Houston
- HDH Research- Site Number : 8400104, Houston
- Baylor College of Medicine- Site Number : 8400076, Houston
- 以及另外 2 项
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
招募中3 期
- SE Houston- Site Number : 8400120, Houston
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
招募中2 期
- Research Site, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
招募中2 期
- Baylor College of Medicine, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
招募中3 期
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
招募中3 期
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · 距离 17 英里
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
招募中2/3 期
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
招募中3 期
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
STRIVE Post-Market Registry Study
招募中观察性研究
- University of Texas Health Science Center at Houston, Houston
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
招募中3 期
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
招募中
- Houston Methodist/Primary Critical Care, Houston
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
招募中3 期
- GSK Investigational Site, Houston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
招募中观察性研究
- Horizon Clinical Research Group, Houston
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
招募中
- Respire Research Institute, Houston
其他城市的 慢性阻塞性肺病试验
- Philadelphia, PA22 项研究
- Birmingham, AL18 项研究
- Miami, FL18 项研究
- Boston, MA17 项研究
- Orlando, FL15 项研究
- Chicago, IL14 项研究
- Pittsburgh, PA13 项研究
- Baltimore, MD13 项研究
- Dallas, TX12 项研究
- New York City, NY11 项研究
- Ann Arbor, MI10 项研究
- Phoenix, AZ9 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）123 项研究
- 转移性癌症104 项研究
- 结直肠癌102 项研究
- 卵巢癌89 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。